The Proprotein Convertase Subtilisin/Kexin Type 9-resistant R410S Low Density Lipoprotein Receptor Mutation-Reference-Cited by-同舟云学术

The Proprotein Convertase Subtilisin/Kexin Type 9-resistant R410S Low Density Lipoprotein Receptor Mutation

Published:2017-02 Issue:5 Volume:292 Page:1573-1590
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Susan-Resiga Delia,Girard Emmanuelle,Kiss Robert Scott,Essalmani Rachid,Hamelin Josée,Asselin Marie-Claude,Awan Zuhier,Butkinaree Chutikarn,Fleury Alexandre,Soldera Armand,Dory Yves L.,Baass Alexis,Seidah Nabil G.^ORCID

Funder

Canadian Institutes of Health Research

Canada Excellence Research Chairs, Government of Canada

Pfizer

Fondation Leducq

University of Pennsylvania

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference71 articles.

1. Intensive lipid lowering with atorvastatin in patients with stable coronary disease;LaRosa;N. Engl. J. Med,2005

2. Ezetimibe added to statin therapy after acute coronary syndromes;Cannon;N. Engl. J. Med,2015

3. A receptor-mediated pathway for cholesterol homeostasis;Brown;Science,1986

4. The Metabolic and Molecular Bases of Inherited Disease;Goldstein,2001

5. LOVD Version 2.0: the next generation in gene variant databases;Fokkema;Hum. Mutat,2011

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): from bench to bedside;Signal Transduction and Targeted Therapy;2024-01-08

2. Advances in familial hypercholesterolemia;Advances in Clinical Chemistry;2024

3. Pharmacogenomics of Cardiovascular Drugs for Atherothrombotic, Thromboembolic and Atherosclerotic Risk;Genes;2023-11-09

4. Endocrine Regulation of Microvascular Receptor—Mediated Transcytosis and Its Therapeutic Opportunities: Insights by PCSK9—Mediated Regulation;Pharmaceutics;2023-04-18

5. LDLR missense variants disturb structural conformation and LDLR activity in T-lymphocytes of Familial hypercholesterolemia patients;Gene;2023-02